Worldwide: Insurance

Generative artificial intelligence cannot be avoided or ignored, but its risks can be managed. As organizations increasingly deploy Gen AI in marketing, customer interactions and operational decision-making, they are also assuming risk for the outputs those systems generate.

The Pharmacy Benefit Management (PBM) Working Group is moving toward a more robust, standardized PBM examination and oversight framework—expanding focus to affiliated entities...

A recurring question in coverage disputes is whether a sub-limit expands coverage by creating a new, defined grant...

In recent years, ceding companies and reinsurers across major jurisdictions around the world have faced increasing scrutiny from insurance regulators regarding the use of cross-border asset-intensive reinsurance...

On 3 February 2026, the European Insurance and Occupational Pensions Authority (EIOPA) published its Consultation Paper on a Supervisory Statement on the Authorisation and Ongoing Supervision...

Large-scale class actions and mass torts pose unique and significant challenges for insurers, far exceeding the complexity of most individual or smaller-scale litigation.